Albert J. Robichaud
2014
In 2014, Albert J. Robichaud earned a total compensation of $400.3K as Chief Scientific Officer at Sage Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $99,000 |
|---|---|
| Salary | $300,000 |
| Other | $1,275 |
| Total | $400,275 |
Robichaud received $300K in salary, accounting for 75% of the total pay in 2014.
Robichaud also received $99K in non-equity incentive plan and $1.3K in other compensation.
Rankings
In 2014, Albert J. Robichaud's compensation ranked 11,005th out of 13,032 executives tracked by ExecPay. In other words, Robichaud earned more than 15.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,005 out of 13,032 | 16th |
Division Manufacturing | 4,210 out of 4,967 | 15th |
Major group Chemicals And Allied Products | 1,457 out of 1,690 | 14th |
Industry group Drugs | 1,173 out of 1,369 | 14th |
Industry Pharmaceutical Preparations | 898 out of 1,042 | 14th |
Source: SEC filing on April 17, 2015.
Robichaud's colleagues
We found two more compensation records of executives who worked with Albert J. Robichaud at Sage Therapeutics in 2014.
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019